Moxifloxacin As Part of a Multi-Drug Regimen For Tuberculosis
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
Current treatment of tuberculosis (TB) requires patients to take four drugs for 8 weeks and
then two drugs for 4 months. New drug regimens that are shorter and effective against
drug-resistant TB are needed. This study will evaluate whether using the drug moxifloxacin
(MOX) in place of ethambutol (EMB) during the first 8 weeks of treatment will effectively
treat TB.
Phase:
Phase 2
Details
Lead Sponsor:
Johns Hopkins University
Treatments:
Fluoroquinolones Moxifloxacin Norgestimate, ethinyl estradiol drug combination